(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADOCIA, DGB GROUP N.V., and BERGENBIO.

Financial Asset	Price	Change	Updated (EST)
ADOCIA (ADOC.PA)	8.23	15.1%	2024-06-26 12:46:33
DGB GROUP N.V. (DGB.AS)	0.78	11.14%	2024-06-26 12:01:30
BERGENBIO (BGBIO.OL)	12.33	7.7%	2024-06-26 12:26:43
AMPLITUDE SURGICAL (AMPLI.PA)	3.50	7.36%	2024-06-26 12:47:27
ELLIPTIC LABORATOR (ELABS.OL)	10.54	6.36%	2024-06-26 12:27:56
STRONGPOINT (STRO.OL)	12.60	6.33%	2024-06-26 12:44:53
ULTIMOVACS (ULTI.OL)	8.25	5.74%	2024-06-26 12:45:21
VOW (VOW.OL)	6.18	5.17%	2024-06-26 12:45:33
PETROLIA (PSE.OL)	5.15	5.1%	2024-06-26 12:42:42
ENSURGE MICROPOWER (ENSU.OL)	1.44	4.45%	2024-06-26 12:28:04

The three biggest losers today are ALFEN, VIVORYON, and EBUSCO HOLDING.

Financial Asset	Price	Change	Updated (EST)
ALFEN (ALFEN.AS)	15.46	-51.6%	2024-06-26 12:00:19
VIVORYON (VVY.AS)	1.41	-20.2%	2024-06-26 12:04:31
EBUSCO HOLDING (EBUS.AS)	1.71	-17.35%	2024-06-26 12:01:39
ACCSYS (AXS.AS)	0.66	-11.65%	2024-06-26 12:00:06
IBA (IBAB.BR)	11.72	-11.35%	2024-06-26 12:20:11
SALMONES CAMANCHAC (SACAM.OL)	15.90	-10.67%	2024-06-26 12:43:23
FUT.CLUBE PORTO (FCP.LS)	1.19	-7.75%	2024-06-26 12:24:00
ATEME (ATEME.PA)	4.11	-7.64%	2024-06-26 12:47:50
NEPI ROCKCASTLE (NRP.AS)	6.60	-6.38%	2024-06-26 12:03:03
TEKNA HOLDING (TEKNA.OL)	5.12	-5.88%	2024-06-26 12:45:02

Winners today

1. ADOCIA (ADOC.PA)

15.1% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA rising 15.1% to €8.23 on Wednesday while CAC 40 dropped 0.69% to €7,609.15.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Volume

Today’s last reported volume for ADOCIA is 230320 which is 166.52% above its average volume of 86415.

Moving Average

ADOCIA’s worth is under its 50-day moving average of €9.07 and way above its 200-day moving average of €6.63.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.17%, a negative 1.25%, and a positive 2.86%.

ADOCIA’s highest amplitude of average volatility was 4.75% (last week), 3.11% (last month), and 2.86% (last quarter).

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €8.23 at 22:40 EST, way below its 52-week high of €16.16 and way above its 52-week low of €2.74.

More news about ADOCIA.

2. DGB GROUP N.V. (DGB.AS)

11.14% Price Change

DGB Group N.V. invests in, develops, and manages carbon credits and biodiversity projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising removing or avoiding carbon emissions, tackling social, and environmental challenges; manages projects that focuses on ecosystem restoration, habitat conservation, and biodiversity enrichment; and undertakes plastic projects, which consists of removing and recycling plastic, waste reduction, and environmental conservation works, as well as carbon offsetting projects for reducing carbon footprint of companies. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. rising 11.14% to €0.78 on Wednesday while AEX-Index slid 0.38% to €923.13.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.73%.

Volume

Today’s last reported volume for DGB GROUP N.V. is 81073 which is 386.89% above its average volume of 16651.

More news about DGB GROUP N.V..

3. BERGENBIO (BGBIO.OL)

7.7% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 7.7% to €12.33 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.09% to €1,409.24.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr67.

PE Ratio

BERGENBIO has a trailing twelve months price to earnings ratio of 0.18. Meaning, the purchaser of the share is investing kr0.18 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

More news about BERGENBIO.

4. AMPLITUDE SURGICAL (AMPLI.PA)

7.36% Price Change

Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of January 21, 2021, Amplitude Surgical SA operates as a subsidiary of PAI Partners.

CAC 40 ended the session with AMPLITUDE SURGICAL jumping 7.36% to €3.50 on Wednesday while CAC 40 fell 0.69% to €7,609.15.

Earnings Per Share

As for profitability, AMPLITUDE SURGICAL has a trailing twelve months EPS of €-0.06.

Volume

Today’s last reported volume for AMPLITUDE SURGICAL is 20781 which is 345.37% above its average volume of 4666.

More news about AMPLITUDE SURGICAL.

5. ELLIPTIC LABORATOR (ELABS.OL)

6.36% Price Change

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It also provides AI Virtual Position Sensor which automatically detects the location of an external display in relation to a laptop; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology, that enables touchless user interactions; AI Virtual Breathing sensor that enables to track person's breathing; and AI Virtual heart Sensor that tracks a person's heart rate. The company was incorporated in 2006 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELLIPTIC LABORATOR jumping 6.36% to €10.54 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.09% to €1,409.24, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ELLIPTIC LABORATOR has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.11%.

Sales Growth

ELLIPTIC LABORATOR’s sales growth is negative 29.8% for the ongoing quarter and 367.1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 244.9%, now sitting on 74.16M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 266.7% and positive 155.6% for the next.

More news about ELLIPTIC LABORATOR.

6. STRONGPOINT (STRO.OL)

6.33% Price Change

StrongPoint ASA develops, sells, and implements integrated technology solutions for in-store and online shopping in Scandinavia and internationally. The company offers various products and solutions comprising electronic shelf labels, scales and wrapping systems, and humanoid grocery robots; order and in-store picking, autonomous mobile robots, home delivery, grocery lockers, drive-thru, warehouse management system, and automated micro-fulfilment solutions; CashGuard, a cash management system; shop fitting services; and self-checkout solutions, as well as other retail technology comprising enterprise resource management system, point of sale software and terminals, fiscal printer, and other technologies. It also provides ShopFlow Logistics, a cloud based mobile logistics system for handling routines, such as receiving goods, inventory, balance adjustment, ordering labels printing, and waste management; and Vensafe, which automates in-store sales of restricted and theft-prone products. The company has a strategic partnership with Halodi Robotics to develop an in-store grocery retail robotics solution. It serves the grocery, pharmacy, do-it-yourself, fashion, and sports retail markets. The company was formerly known as PSI Group ASA and changed its name to StrongPoint ASA in September 2015. StrongPoint ASA was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with STRONGPOINT rising 6.33% to €12.60 on Wednesday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.09% to €1,409.24, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, STRONGPOINT has a trailing twelve months EPS of kr-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.91%.

Sales Growth

STRONGPOINT’s sales growth is negative 18.3% for the ongoing quarter and negative 7.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 1.32B for the twelve trailing months.

Moving Average

STRONGPOINT’s value is above its 50-day moving average of kr11.95 and way under its 200-day moving average of kr14.19.

Volume

Today’s last reported volume for STRONGPOINT is 238524 which is 115.6% above its average volume of 110630.

More news about STRONGPOINT.

7. ULTIMOVACS (ULTI.OL)

5.74% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS rising 5.74% to €8.25 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.09% to €1,409.24.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -52.14%.

Moving Average

ULTIMOVACS’s worth is above its 50-day moving average of kr8.14 and way below its 200-day moving average of kr80.82.

Yearly Top and Bottom Value

ULTIMOVACS’s stock is valued at kr8.25 at 22:40 EST, way under its 52-week high of kr178.60 and way above its 52-week low of kr6.07.

More news about ULTIMOVACS.

8. VOW (VOW.OL)

5.17% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW jumping 5.17% to €6.18 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.09% to €1,409.24.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.86%.

Yearly Top and Bottom Value

VOW’s stock is valued at kr6.18 at 22:40 EST, way under its 52-week high of kr17.80 and way above its 52-week low of kr4.80.

Volatility

VOW’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.17%, a negative 0.30%, and a positive 3.40%.

VOW’s highest amplitude of average volatility was 1.45% (last week), 2.39% (last month), and 3.40% (last quarter).

More news about VOW.

9. PETROLIA (PSE.OL)

5.1% Price Change

Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates in two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as production of hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with PETROLIA jumping 5.1% to €5.15 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.09% to €1,409.24, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, PETROLIA has a trailing twelve months EPS of kr0.32.

PE Ratio

PETROLIA has a trailing twelve months price to earnings ratio of 16.09. Meaning, the purchaser of the share is investing kr16.09 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.43%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 13.1%, now sitting on 54.2M for the twelve trailing months.

Moving Average

PETROLIA’s value is higher than its 50-day moving average of kr4.77 and way above its 200-day moving average of kr4.37.

More news about PETROLIA.

10. ENSURGE MICROPOWER (ENSU.OL)

4.45% Price Change

Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 4.45% to €1.44 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.09% to €1,409.24.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-3.33.

Volume

Today’s last reported volume for ENSURGE MICROPOWER is 2789520 which is 69.51% below its average volume of 9150420.

More news about ENSURGE MICROPOWER.

Losers Today

1. ALFEN (ALFEN.AS)

-51.6% Price Change

Alfen N.V., through its subsidiaries, engages in the design, engineering, development, production, and service of smart grids, energy storage systems, and electric vehicle charging equipment. The company offers smart grid solutions, including secondary transformer substations for grid operators, devices for grid automation, and proprietary back-end systems for remote management and control of electricity grids, as well as micro-grids; and supplementary offerings to grid connect amongst others PV farms, electric vehicle (EV) fast-charging hubs, and industrial companies. It also provides energy storage systems comprising stationary and mobile battery energy storage solutions for load balancing, peak shaving, grid frequency control, and energy trading solutions, as well as embedded software and back-office solutions that enables remote monitoring, control, and support for storage applications. In addition, the company offers smart and connected electric vehicle chargers for use at the home, retail, workplace, and public locations, as well as an online management platform for charging infrastructure and standardized solutions for smart charging, load balancing, charging hubs, and plug and charge functionalities. It operates primarily in the Netherlands, Austria, Belgium, Finland, France, Germany, Italy, Norway, Poland, Spain, Sweden, Switzerland, the United Kingdom, and the rest of Europe. The company was founded in 1937 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ALFEN sliding 51.6% to €15.46 on Wednesday while AEX-Index slid 0.38% to €923.13.

Earnings Per Share

As for profitability, ALFEN has a trailing twelve months EPS of €1.36.

PE Ratio

ALFEN has a trailing twelve months price to earnings ratio of 11.37. Meaning, the purchaser of the share is investing €11.37 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.98%.

Yearly Top and Bottom Value

ALFEN’s stock is valued at €15.46 at 22:40 EST, way under its 52-week low of €27.31.

Moving Average

ALFEN’s value is way below its 50-day moving average of €37.08 and way below its 200-day moving average of €44.47.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALFEN’s stock is considered to be overbought (>=80).

Volatility

ALFEN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.07%, a negative 0.63%, and a positive 3.16%.

ALFEN’s highest amplitude of average volatility was 1.85% (last week), 2.40% (last month), and 3.16% (last quarter).

More news about ALFEN.

2. VIVORYON (VVY.AS)

-20.2% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON sliding 20.2% to €1.41 on Wednesday while AEX-Index dropped 0.38% to €923.13.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

More news about VIVORYON.

3. EBUSCO HOLDING (EBUS.AS)

-17.35% Price Change

Ebusco Holding N.V., together with its subsidiaries, engages in the development, manufacture, and distribution of zero emission buses and charging systems. It also provides ancillary products and services to electric vehicle ecosystem; and manufactures and supplies energy storage systems and mobile energy containers, as well as repair and maintenance services. The company operates in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING dropping 17.35% to €1.71 on Wednesday, after three successive sessions in a row of losses. AEX-Index fell 0.38% to €923.13, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-2.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.19%.

More news about EBUSCO HOLDING.

4. ACCSYS (AXS.AS)

-11.65% Price Change

Accsys Technologies PLC, together with its subsidiaries, engages in the production and sale of solid wood and wood elements in the United Kingdom, Ireland, rest of Europe, the Americas, and internationally. It offers solid acetylated wood for use in windows, doors, shutters, decking, and cladding under the Accoya brand; and wood chips to manufacture panel products under the Tricoya brand. The company also provides technical and engineering services to licensees, as well as sales and marketing services; sells acetic acid; manufactures colored acetylated wood. Accsys Technologies PLC was incorporated in 2005 and is headquartered in London, the United Kingdom.

AEX-Index ended the session with ACCSYS sliding 11.65% to €0.66 on Wednesday, after two consecutive sessions in a row of gains. AEX-Index fell 0.38% to €923.13, after two successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ACCSYS has a trailing twelve months EPS of €-0.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.74%.

Volume

Today’s last reported volume for ACCSYS is 591474 which is 405.09% above its average volume of 117102.

Volatility

ACCSYS’s last week, last month’s, and last quarter’s current intraday variation average was 1.01%, 0.52%, and 1.42%.

ACCSYS’s highest amplitude of average volatility was 1.47% (last week), 1.05% (last month), and 1.42% (last quarter).

More news about ACCSYS.

5. IBA (IBAB.BR)

-11.35% Price Change

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

BEL 20 ended the session with IBA falling 11.35% to €11.72 on Wednesday while BEL 20 slid 1.11% to €3,915.33.

Earnings Per Share

As for profitability, IBA has a trailing twelve months EPS of €-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.2%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IBA’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 428.72M for the twelve trailing months.

Volatility

IBA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.17%, a negative 0.24%, and a positive 1.87%.

IBA’s highest amplitude of average volatility was 3.17% (last week), 1.98% (last month), and 1.87% (last quarter).

Volume

Today’s last reported volume for IBA is 205923 which is 577.53% above its average volume of 30393.

More news about IBA.

6. SALMONES CAMANCHAC (SACAM.OL)

-10.67% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. Salmones Camanchaca S.A. was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Camanchaca S.A.

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC dropping 10.67% to €15.90 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.09% to €1,409.24.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr-2.17.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.32%.

Yearly Top and Bottom Value

SALMONES CAMANCHAC’s stock is valued at kr15.90 at 22:40 EST, way below its 52-week low of kr21.00.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 357.22M for the twelve trailing months.

Sales Growth

SALMONES CAMANCHAC’s sales growth is 64.2% for the current quarter and 12.9% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 3966.7% and 168.8%, respectively.

More news about SALMONES CAMANCHAC.

7. FUT.CLUBE PORTO (FCP.LS)

-7.75% Price Change

Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.

PSI ended the session with FUT.CLUBE PORTO falling 7.75% to €1.19 on Wednesday, following the last session’s downward trend. PSI dropped 0.33% to €6,545.95, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.

Yearly Top and Bottom Value

FUT.CLUBE PORTO’s stock is valued at €1.19 at 22:40 EST, under its 52-week high of €1.30 and way higher than its 52-week low of €1.00.

More news about FUT.CLUBE PORTO.

8. ATEME (ATEME.PA)

-7.64% Price Change

ATEME SA, together with its subsidiaries, produces and sells electronic and computer devices and instruments worldwide. The company offers video processing solutions, such as TITAN Edge Bridge, a low latency 4k baseband converter; TITAN Recorder, a stream-delay solution; TITAN Edge Gateway; TITAN Edge Encoder, a low Latency 4K contribution encoder; TITAN edge Decoder; TITAN Live, software-based live video compression for the converged headend; TITAN File, a video transcoding software; TITAN Mux, a multi-function software stream processing solution; KYRION DR5000, an ultra-low latency receiver decoder; and KYRION CM5000e, an ultra-low latency encoder. It also provides NEA-CDN, an OTT scale service solution; NEA-DVR; NEA-Live for immersive viewing experience; NEA-Composer Dynamic Ad Insertion; NEA Composer Linear Origination; and NEA Genesis. In addition, the company offers PILOT Media, a cloud native media supply chain solution; PILOT Manager, a cloud native management system; PILOT Analytics, a business intelligence for media experiences; and provides SaaS video delivery. It serves its products to the content and service providers. ATEME SA was incorporated in 1991 and is headquartered in Vélizy-Villacoublay, France.

CAC 40 ended the session with ATEME falling 7.64% to €4.11 on Wednesday while CAC 40 fell 0.69% to €7,609.15.

Earnings Per Share

As for profitability, ATEME has a trailing twelve months EPS of €-0.28.

Volatility

ATEME’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 1.53%, and a positive 2.83%.

ATEME’s highest amplitude of average volatility was 1.55% (last week), 2.13% (last month), and 2.83% (last quarter).

Volume

Today’s last reported volume for ATEME is 2734 which is 66.39% below its average volume of 8136.

More news about ATEME.

9. NEPI ROCKCASTLE (NRP.AS)

-6.38% Price Change

NEPI Rockcastle N.V. (“the Company”, “NEPI Rockcastle”, “the Group”) is a public limited company domiciled in the Netherlands, having its registered office at Strawinskylaan 563, WTC Zuidas, Tower Ten, 5th Floor, 1077 XX Amsterdam, with registration number at the Dutch Chamber of Commerce 87488329. The Company's shares are listed on the Main Board of the Johannesburg Stock Exchange Limited (“JSE”), Euronext Amsterdam and A2X. NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (“CEE”). The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise.

AEX-Index ended the session with NEPI ROCKCASTLE dropping 6.38% to €6.60 on Wednesday while AEX-Index dropped 0.38% to €923.13.

Earnings Per Share

As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.75.

PE Ratio

NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing €8.8 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.62%.

More news about NEPI ROCKCASTLE.

10. TEKNA HOLDING (TEKNA.OL)

-5.88% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING falling 5.88% to €5.12 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.09% to €1,409.24, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.02%.

More news about TEKNA HOLDING.

Stay up to date with our winners and losers daily report